Biotech · Private company
ISA Pharmaceuticals
Track this companyFree. Adds ISA Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CemiplimabPhase 2 · Squamous Cell Carcinoma of the OropharynxClinicalTrials.gov · fetched Nov 12, 2026
- ISA101bPhase 2 · Squamous Cell Carcinoma of the OropharynxClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPCPHASE2 · UNKNOWN · started Jul 1, 2021ClinicalTrials.gov NCT04398524 · fetched Nov 12, 2026
- HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell CarcinomaPHASE2 · COMPLETED · started Jul 6, 2020ClinicalTrials.gov NCT04369937 · fetched Nov 12, 2026
- A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPCPHASE2 · UNKNOWN · started Nov 30, 2018ClinicalTrials.gov NCT03669718 · fetched Nov 12, 2026